Key Features of the Portal

  • Patient Survey Access

  • Newsletter

  • Analytics

    • Demographic dashboards

    • Function, Health and Satisfaction of

    • Treatment dashboards

    • Outcomes dashboards

  • Research

    • Patient Guide

    • Current Research Studies

    • Mechanism for researchers to submit proposals for research of the portal data

  • Education & Support

    • Resources for Eye Habits and Health

    • Local Education and Support Groups

    • Transportation Assistance Resources

    • Early Detection & Genetics, Managing the

    • Disease, Compliance with Treatment

    • Insurance Tools and Tips

    • Medication Copay Assist Programs

    • SDOH/Health Equity

    • Barriers to Adherence to Treatment

More than 22 million Americans are living with age-related macular degeneration (AMD)

Online resources for people living with AMD are decentralized and there is no single source of truth where this community can receive accurate and current guidance.

Eyes on the Future is a portal for doctors, patients and care providers that will harness the power of healthcare analytics to uncover patterns, trends, and correlations within the data to improve patient care by helping the community:

  • Address issues of wide concern

    • Where to find resources for support and treatment

    • Where to get assistance with treatment costs

    • Privacy and security of the patient data that is stored in the portal

  • Communicate Choices

    • Awareness of symptoms

    • Importance of early diagnosis

    • Treatment options

    • Express the value of participating in the portal

  • Collect Patient Data to Support Analytics and Research

    • Collect data using standardized surveys for visual function, general health, satisfaction of treatment and symptom state

    • Collect patient demographic data to support research and analytics

Partnering for a broader reach

The Thought Leadership & Innovation Foundation is collaborating with the American Macular Degeneration Foundation (AMDF) to expand our individual capabilities to reach the millions of people who are affected by AMD.